BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 175,999,345
- Share change
- +745,157
- Total reported value
- $13,600,848,412
- Put/Call ratio
- 187%
- Price per share
- $77.29
- Number of holders
- 498
- Value change
- +$49,734,828
- Number of buys
- 232
- Number of sells
- 211
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
11%
|
22,086,389
|
$1,842,889,000 | — | 30 Jun 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
9.3%
|
17,953,066
|
$1,498,004,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
16,222,594
|
$1,353,613,000 | — | 30 Jun 2021 | |
| DODGE & COX |
13F
|
Company |
7.3%
|
14,102,097
|
$1,176,679,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
12,895,568
|
$1,076,006,000 | — | 30 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.9%
|
7,589,294
|
$633,251,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.4%
|
6,550,249
|
$546,558,000 | — | 30 Jun 2021 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.6%
|
5,071,303
|
$423,150,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
4,907,057
|
$409,445,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2%
|
3,954,190
|
$329,940,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
3,755,379
|
$313,348,000 | — | 30 Jun 2021 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
1.4%
|
2,684,874
|
$224,026,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
2,308,922
|
$192,379,000 | — | 30 Jun 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
1.1%
|
2,212,950
|
$184,649,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
2,168,045
|
$180,902,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
2,041,483
|
$170,341,341 | — | 30 Jun 2021 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.9%
|
1,727,384
|
$144,131,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.89%
|
1,710,741
|
$142,744,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.86%
|
1,660,316
|
$138,537,000 | — | 30 Jun 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.86%
|
1,650,000
|
$137,676,000 | — | 30 Jun 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.81%
|
1,554,221
|
$129,684,000 | — | 30 Jun 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.67%
|
1,296,440
|
$108,175,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
1,284,445
|
$107,175,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
1,251,138
|
$104,396,000 | — | 30 Jun 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.63%
|
1,215,874
|
$101,453,000 | — | 30 Jun 2021 | |
| NATIXIS |
13F
|
Company |
0.63%
|
1,212,590
|
$101,179,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.61%
|
1,176,891
|
$98,200,000 | — | 30 Jun 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.58%
|
1,111,878
|
$92,775,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.51%
|
983,016
|
$82,023,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.5%
|
960,162
|
$80,116,000 | — | 30 Jun 2021 | |
| Davide Leone & Partners Investment Co Ltd. |
13F
|
Company |
0.49%
|
954,454
|
$79,640,000 | — | 30 Jun 2021 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.42%
|
813,453
|
$67,872,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.38%
|
742,798
|
$61,979,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
740,498
|
$61,788,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.37%
|
716,485
|
$59,784,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.36%
|
694,844
|
$57,978,000 | — | 30 Jun 2021 | |
| Fiera Capital Corp |
13F
|
Company |
0.35%
|
672,426
|
$56,107,000 | — | 30 Jun 2021 | |
| USS Investment Management Ltd |
13F
|
Company |
0.32%
|
623,186
|
$52,014,000 | — | 30 Jun 2021 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.32%
|
619,088
|
$51,657,000 | — | 30 Jun 2021 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.32%
|
618,322
|
$51,593,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.32%
|
616,320
|
$51,426,000 | — | 30 Jun 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.31%
|
606,208
|
$50,582,000 | — | 30 Jun 2021 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.31%
|
604,900
|
$50,474,524 | — | 30 Jun 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.3%
|
587,361
|
$49,009,000 | — | 30 Jun 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.29%
|
550,856
|
$45,963,000 | — | 30 Jun 2021 | |
| Capital International Investors |
13F
|
Company |
0.28%
|
548,043
|
$45,729,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.27%
|
520,881
|
$43,462,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
473,662
|
$39,522,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.24%
|
471,887
|
$39,375,000 | — | 30 Jun 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.24%
|
460,073
|
$38,389,000 | — | 30 Jun 2021 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q3 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.